<DOC>
	<DOCNO>NCT00372879</DOCNO>
	<brief_summary>Muscular cramp common uncomfortable symptom amyotrophic lateral sclerosis ( ALS ) . This clinical trial compare response high dose vitamin E supplementation placebo treatment muscular cramp patient ALS . We hypothesize vitamin E effective placebo treat cramp .</brief_summary>
	<brief_title>Clinical Trial Vitamin E Treat Muscular Cramps Patients With ALS</brief_title>
	<detailed_description>This single centre randomize placebo control crossover design trial . Participants randomize study entry protocol A ( vitamin E first ) protocol B ( placebo first ) . The first 2 week study baseline assessment frequency , severity duration cramp . Patients blind remainder duration study . For week 3-6 study , group A receive vitamin E 800 IU bid group B receive placebo . For week 7-10 study , group A receive placebo group B receive vitamin E. Participants record cramp frequency characteristic via daily journal duration study , however data analysis focus cramp frequency week 5-6 9-10 . Weeks 3-4 7-8 used time period allow new drug come steady state allow washout previous drug . Data analysis focus difference cramp frequency individual patient treatment period .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<criteria>Adults ( &gt; age 18 year ) Probable definite ALS El Escorial Revised criterion At least 2 painful muscle cramp one limb per week . May try medication cramp past . If participant currently treatment cramp continue least 2 cramp per week , include trial . In situation , individual 's previous cramp medication continue trial . Ideally , patient medication alteration duration trial . Willing discontinue supplementary vitamin E multivitamins contain &gt; 400 IU vitamin E trial . Patients unable safely consume trial capsule . Individuals significant dysphagia include study function PEG tube GJ tube , medication give . Patients unable fill daily diary , either personally via proxy . Patients medication change within last 4 week prior onset trial exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>amyotrophic lateral sclerosis</keyword>
	<keyword>vitamin E</keyword>
	<keyword>muscle cramp</keyword>
</DOC>